theophylline has been researched along with pentoxifylline in 88 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 26 (29.55) | 18.7374 |
1990's | 28 (31.82) | 18.2507 |
2000's | 18 (20.45) | 29.6817 |
2010's | 11 (12.50) | 24.3611 |
2020's | 5 (5.68) | 2.80 |
Authors | Studies |
---|---|
Hasegawa, T; Iwasaki, N; Konno, K; Kurita, M; Miyamoto, K; Ohshima, T; Sakai, R; Sanae, F; Takagi, K; Yamamoto, Y | 1 |
Topliss, JG; Yoshida, F | 1 |
Jacobson, KA; Kim, HS; Kim, SA; Linden, J; Marshall, MA; Melman, N; Müller, CE | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Andersen, OA; Demartino, JA; Rao, FV; van Aalten, DM; Vora, KA | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Gwizdek-Wiśniewska, A; Piosik, J; Ulanowska, K; Wegrzyn, G | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Gołuński, G; Iermak, I; Piosik, J; Rychłowski, M; Woziwodzka, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Bucki, A; Chłoń-Rzepa, G; Gawalska, A; Jankowska, A; Kołaczkowski, M; Pawłowski, M; Pociecha, K; Ślusarczyk, M; Świerczek, A; Wyska, E | 1 |
Cardinali, DP | 1 |
Cartheuser, C; Komarek, J | 1 |
Boksay, I; Csanyi, V; Gervai, J; Lajtha, A | 1 |
Bang, YJ; Danielpour, D; Kim, KY; Kim, SJ; Myers, CE; O'Reilly, MA; Trepel, JB | 1 |
Gottehrer, A; Vaughan, LM | 1 |
Blaskó, G; Hermecz, I; Kapui, Z; Sarkadi, B; Szentmiklósi, P; Tardos, L | 1 |
McCall, JL; Parry, BR; Tuckey, JA | 1 |
Bardenheuer, H; Madel, C; Peter, K; Pöch, G; Thiel, M | 1 |
Schmid-Schönbein, GW; Wong, PM | 1 |
Mitsumoto, Y; Mohri, T; Ohkubo, T | 1 |
Goto, M; Hayashi, S; Sakurai, M; Tanaka, Y | 1 |
Cummings, DM; Ellison, MJ; Horner, RD; Willis, SE | 1 |
Kunkel, SL; Larrick, J; Lynch, JP; Remick, DG; Spengler, RN; Strieter, RM; Ward, PA | 1 |
Lupal'tsev, VI | 1 |
El'skaia, IE; Neugodov, IuV; Popov, VV; Sokolov, GF | 1 |
Sasaki, T; Tomita, K; Tsuchiya, H | 1 |
Morton, MR; Parish, RC; Spruill, WJ | 1 |
Freyburger, G; Hammerschmidt, DE; Huh, PW; Kotasek, D; McCarthy, T; Vercellotti, GM | 1 |
Cohen, IA; Converse-Swastek, K; Johnson, CE; Wesolowicz, L | 1 |
Gómez Reyes, D; Rojas Hidalgo, E | 2 |
Grossmann, K; Knischka, A | 1 |
Luke, DR; Rocci, ML; Saccar, CL | 1 |
Pivovarova, EIa; Samsonov, AA; Vorob'ev, LP | 1 |
Belinskaia, TF; Li, ED; Makoeva, LD; Margarian, AG; Sabaev, VV | 1 |
Cummings, DM; Green, P; Rocci, ML; Saccar, C | 1 |
Nuzov, BG | 1 |
Aparicio, M; Basabe, JC; Cresto, JC; Fabiano de Bruno, L; Karabatas, L | 1 |
Herman, G; Mauduit, P; Rossignol, B | 1 |
Argel, MI; Chiappe, GE; Chiappe, LE; Cingolani, HE; Grassi, AO; Vittone, L | 1 |
Bourguet, J; Favard, P | 1 |
Beyreder, J | 1 |
Benignetti, G; Benvenuti, C; Fabbri, F | 1 |
Kasabian, IN; Kukes, VG; Mamaeva, GG; Spesivtseva, VG | 1 |
Himberg, JJ; Johnsson, R | 1 |
Hirota, S; Iwazaki, A; Miyagishima, A; Nozawa, Y; Sadzuka, Y | 1 |
Moriuchi, H; Yuizono, T | 1 |
Chapman, MG; Forman, RG; Gearon, CM; Guglielmino, A; Lanzafame, F | 1 |
Hatake, K; Hishida, S; Marukawa, S; Wakabayashi, I | 1 |
Beleta, J; Bou, J; Cardelús, I; Cortijo, J; Gristwood, RW; Llenas, J; Morcillo, E | 1 |
Alléra, A; Eisenhut, T; Endres, S; Gebert, U; Moeller, J; Schönharting, MM; Semmler, J | 1 |
Baudet, S; Binet, JL; Mentz, F; Merle-Béral, H; Ouaaz, F | 1 |
Langermans, JA; Seijmonsbergen, EM; van der Meide, PH; van Furth, AM; van Furth, R | 1 |
Binet, JL; Leblond, V; Mentz, F; Merle-Beral, H | 1 |
Barancík, M; Breier, A; Stefanková, Z | 1 |
Akaike, N; Kawa, K; Uneyama, H | 1 |
Koren, R; Liberman, UA; Ravid, A; Saati, N | 1 |
Aparicio, M; Cambar, J; Potier, M | 1 |
Braune, J; Ebert, U; Grossmann, M; Kirch, W | 1 |
Bitter-Suermann, S; Burdon, D; Entzian, P; Ernst, M; Schlaak, M; Zabel, P | 1 |
Buratti, T; Dunzendorfer, S; Herold, M; Kähler, CM; Reinisch, N; Schratzberger, P; Tilg, H; Wiedermann, CJ | 1 |
Sawada, M; Suzumura, A; Takayanagi, T; Tamaru, T; Yoshikawa, M | 1 |
Daly, JW; Shi, D | 1 |
Freichel, OL; Lippold, BC | 1 |
Baba, A; Enomoto, R; Lee, E; Matsuda, T; Mori, K; Takuma, K | 1 |
Boobis, AR; Edwards, RJ; Murray, BP; Murray, S; Odupitan, AO | 1 |
Ghofrani, HA; Grimminger, F; Leuchte, H; Roehl, A; Schermuly, RT; Seeger, W; Walmrath, D; Weissmann, N | 1 |
Savage, N; Uboldi, AD | 1 |
Czyz, A; Gwizdek-Wiśniewska, A; Ochociński, J; Piosik, J; Ulanowska, K; Wegrzyn, G | 1 |
Finocchiaro, S; Levine, RA; Nandi, J; Ong, G; Saud, B | 1 |
Ulanowska, K; Wegrzyn, G | 1 |
Anderson, CM; Thwaites, DT | 1 |
Balwinski, KM; Mitchell, SA | 1 |
Gwizdek-Wiśniewska, A; Piosik, J; Woziwodzka, A | 1 |
Cohen, JD; Gallegos, AC; Lau, SS; Mastrandrea, NJ; Monks, TJ; Tham, KY | 1 |
Brooks, MB; Divers, TJ; Hernandez, D; Ness, SL; Stokol, T; Yeo, WM | 1 |
Byrne, PG; Keogh, LM; Silla, AJ | 1 |
Bronskill, SE; Cheng, Y; Kalia, LV; Lacoste, AMB; Maclagan, LC; Marras, C; Tadrous, M; Visanji, NP | 1 |
Bachmann, CM; Grimm, HS; Grimm, MOW; Hartmann, T; Janitschke, D; Lauer, AA; Seyfried, M | 1 |
DuMontier, SP; Ganapathiraju, I; Kable, TJ; Mohr, JD; Sabates, BL; Smith, HL; Trump, MW; Wall, GC | 1 |
Chen, DD; Le Grange, JM; Zhang, JN; Zheng, XF; Zhou, LQ; Zhu, XL | 1 |
Bachmann, CM; Griebsch, LV; Grimm, HS; Grimm, MOW; Hartmann, T; Janitschke, D; Lauer, AA; Pilz, SM; Theiss, EL; Winkler, J | 1 |
4 review(s) available for theophylline and pentoxifylline
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Effect of xanthine-related compounds on a theophylline assay using theophylline oxidase.
Topics: Allopurinol; Chromatography, High Pressure Liquid; Drug Interactions; Humans; Oxidoreductases; Oxypurinol; Pentoxifylline; Theophylline; Xanthines | 1992 |
Methylxanthines in surgery: a bright future?
Topics: Humans; Neoplasms; Pentoxifylline; Respiratory Distress Syndrome; Shock, Septic; Surgical Procedures, Operative; Theophylline; Xanthines | 1992 |
Pharmacological stimulation of sperm motility.
Topics: Caffeine; Deoxyadenosines; Humans; Infertility, Male; Male; Pentoxifylline; Relaxin; Sperm Motility; Theophylline | 1994 |
6 trial(s) available for theophylline and pentoxifylline
Article | Year |
---|---|
Influence of pentoxifylline on steady-state theophylline serum concentrations from sustained-release formulations.
Topics: Adolescent; Adult; Delayed-Action Preparations; Drug Interactions; Female; Humans; Male; Middle Aged; Pentoxifylline; Theophylline | 1990 |
[Teonicol and trental in the treatment of duodenal ulcer].
Topics: Adolescent; Adult; Anti-Ulcer Agents; Clinical Trials as Topic; Duodenal Ulcer; Humans; Middle Aged; Pentoxifylline; Theobromine; Theophylline; Xanthinol Niacinate | 1986 |
Use of pentoxifylline in the treatment of acute cerebrovascular insufficiency.
Topics: Acute Disease; Benzamides; Cerebrovascular Disorders; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hexobendine; Humans; Male; Pentoxifylline; Retrospective Studies; Theobromine; Theophylline | 1983 |
[Use of trental and complamine in the microcirculatory disorders of diabetes mellitus].
Topics: Adult; Aged; Blood; Clinical Trials as Topic; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Hypoglycemic Agents; Male; Microcirculation; Middle Aged; Pentoxifylline; Theobromine; Theophylline; Xanthinol Niacinate | 1980 |
Dilatory effects of phosphodiesterase inhibitors on human hand veins in vivo.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Amrinone; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; Enoximone; Female; Hand; Humans; Male; Pentoxifylline; Phosphodiesterase Inhibitors; Theophylline; Vasodilation; Vasodilator Agents; Veins | 1998 |
Effects of various antiplatelet drugs on ex vivo platelet activation induced by equine herpesvirus type 1.
Topics: Animals; Aspirin; Clopidogrel; Cross-Over Studies; Double-Blind Method; Female; Flow Cytometry; Herpesviridae Infections; Herpesvirus 1, Equid; Horse Diseases; Horses; Male; Pentoxifylline; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Theophylline; Ticlopidine | 2016 |
78 other study(ies) available for theophylline and pentoxifylline
Article | Year |
---|---|
Bronchodilator activity of xanthine derivatives substituted with functional groups at the 1- or 7-position.
Topics: Administration, Oral; Animals; Bronchial Spasm; Bronchodilator Agents; Guinea Pigs; Heart Rate; Male; Mice; Muscle Relaxation; Structure-Activity Relationship; Trachea; Xanthines | 1993 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.
Topics: Animals; Binding, Competitive; Cell Line; Cloning, Molecular; Humans; Ligands; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2B; Receptors, Purinergic P1; Recombinant Proteins; Structure-Activity Relationship; Xanthines | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Methylxanthine drugs are chitinase inhibitors: investigation of inhibition and binding modes.
Topics: Chitinases; Enzyme Inhibitors; Models, Molecular; Molecular Structure; Protein Binding; Xanthines | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Impaired mutagenic activities of MPDP(+) (1-methyl-4-phenyl-2,3-dihydropyridinium) and MPP(+) (1-methyl-4-phenylpyridinium) due to their interactions with methylxanthines.
Topics: 1-Methyl-4-phenylpyridinium; Caffeine; Calorimetry; Drug Interactions; Models, Molecular; Molecular Structure; Mutagens; Pentoxifylline; Pyridinium Compounds; Spectrophotometry, Atomic; Vibrio | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Modulation of acridine mutagen ICR191 intercalation to DNA by methylxanthines--analysis with mathematical models.
Topics: Aminacrine; Animals; Caffeine; Cattle; DNA; Drug Antagonism; Epithelial Cells; Intercalating Agents; Kidney; Kinetics; Models, Chemical; Mutagens; Nitrogen Mustard Compounds; Pentoxifylline; Salmonella typhimurium; Theophylline; Thermodynamics | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Novel butanehydrazide derivatives of purine-2,6-dione as dual PDE4/7 inhibitors with potential anti-inflammatory activity: Design, synthesis and biological evaluation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Butanes; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 7; Dose-Response Relationship, Drug; Drug Design; Endotoxemia; Humans; Hydrazines; Lipopolysaccharides; Male; Molecular Structure; Phosphodiesterase Inhibitors; Purinones; Rats; Rats, Wistar; Structure-Activity Relationship | 2018 |
Effects of pentoxifylline and theophylline on neurotransmitter uptake and release by synaptosome-rich homogenates of the rat hypothalamus.
Topics: Animals; Bucladesine; Dopamine; Glutamates; Hypothalamus; Male; Neurotransmitter Agents; Norepinephrine; Pentoxifylline; Potassium; Rats; Serotonin; Synaptosomes; Theobromine; Theophylline; Xanthines | 1977 |
[Effect of pentoxifylline, xanthinol nicotinate and theophylline on the cardiovascular system, myocardial dynamics and left ventricular contractility of the dog in short-system, experiments].
Topics: Animals; Dogs; Hemodynamics; Myocardial Contraction; Myocardium; Oxygen Consumption; Pentoxifylline; Theobromine; Theophylline; Time Factors; Xanthinol Niacinate | 1977 |
The influence of methylxanthines on precursor incorporation into protein and RNA of mouse brain.
Topics: Aminophylline; Animals; Animals, Newborn; Brain; Cycloheximide; Isoleucine; Mice; Mice, Inbred Strains; Nerve Tissue Proteins; Penicillins; Pentoxifylline; RNA; Streptomycin; Theophylline; Time Factors; Uridine; Xanthines | 1976 |
Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3.
Topics: 1-Methyl-3-isobutylxanthine; Aprotinin; Blotting, Northern; Bucladesine; Cell Division; Cell Line; Cyclic AMP; Cycloheximide; Dactinomycin; DNA Replication; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Leupeptins; Male; Pentoxifylline; Phenylmethylsulfonyl Fluoride; Prostatic Neoplasms; RNA, Neoplasm; Theophylline; Transcription, Genetic; Transforming Growth Factor beta; Tumor Cells, Cultured | 1992 |
Comparative studies of drotaverine--acephyllinate (Depogen) and pentoxifylline (Trental).
Topics: Animals; Cell Aggregation; Drug Combinations; Drug Evaluation, Preclinical; Erythrocytes; Humans; Leukocytes; Papaverine; Pentoxifylline; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Factor 3; Rabbits; Theophylline | 1992 |
Pentoxifylline does not act via adenosine receptors in the inhibition of the superoxide anion production of human polymorphonuclear leukocytes.
Topics: Adenosine; Dose-Response Relationship, Drug; Drug Combinations; Humans; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pentoxifylline; Purinergic Antagonists; Receptors, Purinergic; Superoxides; Theophylline | 1991 |
Attenuation of spontaneous pseudopod formation in human neutrophils by pentoxifylline.
Topics: Actins; Adult; Complement C5a; Cytoplasm; Dose-Response Relationship, Drug; Endotoxins; Humans; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pentoxifylline; Pseudopodia; Receptors, Purinergic; Theophylline; Time Factors | 1991 |
Characterization of the uptake of adenosine by cultured rat hippocampal cells and inhibition of the uptake by xanthine derivatives.
Topics: 2-Chloroadenosine; Adenosine; Affinity Labels; Animals; Biological Transport; Caffeine; Cells, Cultured; Cytarabine; Dipyridamole; Embryo, Mammalian; Hippocampus; Kinetics; Neuroglia; Neurons; Pentoxifylline; Rats; Sodium; Theophylline; Thioinosine; Tritium; Xanthines | 1991 |
Effect of xanthine derivatives on hippocampal long-term potentiation.
Topics: Animals; Cyclic AMP; Electrodes; Guinea Pigs; Hippocampus; In Vitro Techniques; Male; Norepinephrine; Pentoxifylline; Receptors, Purinergic; Synapses; Synaptic Transmission; Theophylline; Xanthines | 1990 |
Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Biological Assay; Bucladesine; Cyclic AMP; Dinoprostone; Lipopolysaccharides; Mice; Pentoxifylline; Theobromine; Theophylline; Tumor Necrosis Factor-alpha | 1988 |
[Use of a combination of rheopolyglucin, complamin and trental in the complex treatment of acute postoperative pancreatitis].
Topics: Acute Disease; Dextrans; Drug Therapy, Combination; Humans; Pancreatitis; Pentoxifylline; Platelet Aggregation Inhibitors; Postoperative Complications; Theobromine; Theophylline; Xanthinol Niacinate | 1988 |
[The onset of circulatory venous gangrene of the arm and its successful treatment by thrombolysis].
Topics: Adult; Arm; Drug Therapy, Combination; Female; Fibrinolytic Agents; Gangrene; Heparin; Humans; Infusions, Intravenous; Pentoxifylline; Subclavian Vein; Theobromine; Theophylline; Thrombolytic Therapy; Thrombosis; Xanthinol Niacinate | 1989 |
[DNA repair and drug resistance: enhancement of the effects of anticancer agents by DNA repair inhibitors].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Caffeine; Cell Division; Child; Cisplatin; DNA Repair; Doxorubicin; Drug Resistance; Drug Synergism; Humans; Male; Middle Aged; Osteosarcoma; Pentoxifylline; Theophylline; Tumor Cells, Cultured | 1989 |
Lack of theophylline assay interference from pentoxifylline and its metabolites.
Topics: Aged; Fluorescence Polarization; Humans; Pentoxifylline; Theobromine; Theophylline | 1989 |
Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor.
Topics: Blood Platelets; Cell Adhesion; Cell Aggregation; Chemotaxis, Leukocyte; Endothelium, Vascular; Granulocytes; Humans; Pentoxifylline; Platelet Activating Factor; Platelet Adhesiveness; Platelet Aggregation; Superoxides; Theobromine; Theophylline; Thrombin | 1988 |
Effect of pentoxifylline and its metabolites on three theophylline assays.
Topics: Adult; Chromatography, High Pressure Liquid; Drug Interactions; Humans; Immunoenzyme Techniques; Male; Pentoxifylline; Theobromine; Theophylline | 1988 |
[Therapeutic results with xanthine derivatives in the intermittent claudication syndrome in diabetic patients].
Topics: Adult; Aged; Diabetic Angiopathies; Drug Therapy, Combination; Female; Humans; Intermittent Claudication; Male; Middle Aged; Pentoxifylline; Theobromine; Theophylline; Xanthinol Niacinate | 1988 |
[Intra-arterial therapy of arterial occlusive diseases of the extremities].
Topics: Actihaemyl; Adenosine Triphosphate; Anti-Bacterial Agents; Arterial Occlusive Diseases; Drug Therapy, Combination; Female; Humans; Infusion Pumps; Infusions, Intra-Arterial; Ischemia; Leg; Male; Middle Aged; Nicotinyl Alcohol; Pentoxifylline; Theophylline; Tissue Extracts | 1987 |
Pharmacokinetics of pentoxifylline during concomitant theophylline administration to rats.
Topics: Animals; Drug Interactions; Male; Pentoxifylline; Rats; Rats, Inbred Strains; Theobromine; Theophylline | 1987 |
[Xanthinic derivatives in the treatment of intermittent claudication syndrome in diabetic patients].
Topics: Diabetes Complications; Diabetic Angiopathies; Drug Therapy, Combination; Humans; Intermittent Claudication; Pentoxifylline; Theophylline; Xanthinol Niacinate | 1986 |
[Effect of beta-adrenergic blockaders and trental on plasma levels of renin and aldosterone in healthy persons during antiorthostatic hypokinesia].
Topics: Adult; Aldosterone; Humans; Immobilization; Male; Pentoxifylline; Posture; Propranolol; Renin; Theobromine; Theophylline; Time Factors | 1985 |
Interference potential of pentoxifylline and its major metabolite with theophylline assays.
Topics: Biotransformation; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Drug Interactions; Humans; Immunoenzyme Techniques; Pentoxifylline; Theobromine; Theophylline | 1985 |
[Use of teonikol and trental in the combined treatment of patients with suppurative surgical infection and concomitant diabetes mellitus].
Topics: Chronic Disease; Conjunctiva; Diabetes Mellitus; Drug Therapy, Combination; Female; Hemodynamics; Humans; Male; Middle Aged; Pentoxifylline; Plethysmography, Impedance; Surgical Wound Infection; Theobromine; Theophylline; Time Factors; Xanthinol Niacinate | 1985 |
A comparative study of two insulin secretion inhibitors: somatostatin and diazoxide.
Topics: Animals; Arginine; Calcimycin; Diazoxide; Glucose; Imidazoles; Insulin; Insulin Antagonists; Insulin Secretion; Male; Pentoxifylline; Rats; Rats, Inbred Strains; Somatostatin; Theophylline; Tubulin | 1982 |
A tentative explanation of the stimulatory effect of methylxanthines (pentoxifylline and isobutylmethylxanthine) on the secretory process in rat extraorbital lacrimal gland.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Calcium; Carbachol; Dose-Response Relationship, Drug; Lacrimal Apparatus; Male; Norepinephrine; Pentoxifylline; Proteins; Rats; Rats, Inbred Strains; Sympathomimetics; Theobromine; Theophylline; Xanthines | 1981 |
Effect of phosphodiesterase inhibitors on heart contractile behaviour, protein kinase activity and cyclic nucleotide levels.
Topics: Animals; Cyclic AMP; Cyclic GMP; Myocardial Contraction; Myocardium; Nucleotides, Cyclic; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Protein Kinases; Rats; Theophylline | 1980 |
Effects of pentoxifylline and various methylxanthine derivatives on transepithelial water permeability of frog urinary bladder.
Topics: Animals; Cyclic AMP; Dose-Response Relationship, Drug; Epithelium; Osmosis; Pentoxifylline; Permeability; Rana esculenta; Theobromine; Theophylline; Urinary Bladder; Vasopressins; Water; Xanthines | 1981 |
[Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
Topics: Aged; Arterial Occlusive Diseases; Blood Viscosity; Female; Humans; Male; Middle Aged; Pentoxifylline; Theobromine; Theophylline; Xanthinol Niacinate | 1983 |
Thrombocyte aggregation in hereditary spherocytosis.
Topics: Adenosine Diphosphate; Adult; Chromium Radioisotopes; Collagen; Epinephrine; Female; Humans; Male; Middle Aged; Pentoxifylline; Platelet Aggregation; Ristocetin; Spherocytosis, Hereditary; Splenectomy; Theophylline | 1982 |
Effects of methylxanthine derivatives on adriamycin concentration and antitumor activity.
Topics: Animals; Caffeine; Carcinoma, Ehrlich Tumor; Doxorubicin; Drug Synergism; Male; Mice; Pentoxifylline; Theobromine; Theophylline | 1995 |
Pentoxifylline prevents a decrease in arterial oxygen tension in oleic acid-induced lung injury.
Topics: Airway Resistance; Animals; Blood Pressure; Capillary Permeability; Carbon Dioxide; Guinea Pigs; Hydrogen-Ion Concentration; Hypoxia; Oleic Acid; Oleic Acids; Oxygen; Pentoxifylline; Prospective Studies; Pulmonary Circulation; Respiratory Distress Syndrome; Theophylline | 1995 |
Vasorelaxant effects of oxpentifylline and theophylline on rat isolated aorta.
Topics: Animals; Aorta, Thoracic; Arginine; Dose-Response Relationship, Drug; Drug Interactions; Endothelium, Vascular; In Vitro Techniques; Isoproterenol; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitroarginine; Nitroprusside; Pentoxifylline; Rats; Rats, Wistar; Theophylline; Vasodilator Agents | 1994 |
Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Animals; Asthma; Bronchodilator Agents; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Female; Guinea Pigs; Humans; In Vitro Techniques; Isoenzymes; Isoproterenol; Male; Middle Aged; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrrolidinones; Rolipram; Theophylline; Xanthines | 1993 |
Xanthine derivatives: comparison between suppression of tumour necrosis factor-alpha production and inhibition of cAMP phosphodiesterase activity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Pentoxifylline; Theophylline; Tumor Necrosis Factor-alpha; Xanthines | 1993 |
[In vitro induction of apoptosis in chronic lymphoid leukemia B lymphocytes by theophylline: therapeutic applications].
Topics: Aged; Antineoplastic Agents, Alkylating; Apoptosis; Asthma; B-Lymphocytes; Bronchodilator Agents; Chlorambucil; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Pentoxifylline; Remission Induction; Theophylline; Time Factors; Tumor Cells, Cultured; Vasodilator Agents | 1995 |
Effect of xanthine derivates and dexamethasone on Streptococcus pneumoniae-stimulated production of tumor necrosis factor alpha, interleukin-1 beta (IL-1 beta), and IL-10 by human leukocytes.
Topics: Caffeine; Cytokines; Dexamethasone; Glucocorticoids; Humans; Interleukin-1; Interleukin-10; Leukocytes; Pentoxifylline; Streptococcus pneumoniae; Theophylline; Tumor Necrosis Factor-alpha; Xanthines | 1995 |
Synergistic action of alkylating agents and methylxanthine derivatives in the treatment of chronic lymphocytic leukemia.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Drug Synergism; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Pentoxifylline; Phosphodiesterase Inhibitors; Theophylline; Xanthines | 1995 |
Overcoming of P-glycoprotein mediated vincristine resistance of L1210/VCR mouse leukemic cells could be induced by pentoxifyline but not by theophylline and caffeine.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caffeine; Calcium; Calcium Channels; Drug Interactions; Drug Resistance, Neoplasm; Leukemia L1210; Mice; Pentoxifylline; Phosphodiesterase Inhibitors; Theophylline; Tumor Necrosis Factor-alpha; Vincristine | 1996 |
Inhibitory effect of methylxanthines on glycine-induced Cl current in dissociated rat hippocampal neurons.
Topics: Animals; Caffeine; Chloride Channels; Evoked Potentials; Glycine; Hippocampus; In Vitro Techniques; Pentoxifylline; Pyramidal Cells; Rats; Rats, Wistar; Theobromine; Theophylline; Xanthines | 1993 |
1,25-dihydroxyvitamin D3 and agents that increase intracellular adenosine 3',5'-monophosphate synergistically inhibit fibroblast proliferation.
Topics: 24,25-Dihydroxyvitamin D 3; 3',5'-Cyclic-AMP Phosphodiesterases; 3T3 Cells; 8-Bromo Cyclic Adenosine Monophosphate; Adenylyl Cyclases; Animals; Calcitriol; Cell Division; Colforsin; Cyclic AMP; Dinoprostone; Drug Synergism; Mice; Pentoxifylline; Phosphodiesterase Inhibitors; Theophylline | 1997 |
Protective effect of three xanthine derivatives (theophylline, caffeine and pentoxifylline) against the cyclosporin A-induced glomerular contraction in isolated glomeruli and cultured mesangial cells.
Topics: Animals; Caffeine; Cells, Cultured; Cyclosporine; Fluorescent Antibody Technique, Indirect; Glomerular Mesangium; Immunosuppressive Agents; In Vitro Techniques; Kidney Glomerulus; Male; Muscle Contraction; Pentoxifylline; Rats; Rats, Sprague-Dawley; Theophylline; Xanthines | 1997 |
Differences in the anti-inflammatory effects of theophylline and pentoxifylline: important for the development of asthma therapy?
Topics: Adult; Aged; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Blood Cells; Cells, Cultured; Female; Humans; Interferon-gamma; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pentoxifylline; Phytohemagglutinins; Reactive Oxygen Species; Theophylline; Tumor Necrosis Factor-alpha; Xanthines | 1998 |
Mediator-dependent effects of pentoxifylline on endothelium for transmigration of neutrophils.
Topics: 1-Methyl-3-isobutylxanthine; Adjuvants, Immunologic; Bucladesine; Cell Adhesion; Cell Movement; Endothelium, Vascular; Granulocyte Colony-Stimulating Factor; Humans; Interleukin-1; Interleukin-8; Lipopolysaccharides; Neutrophils; Pentoxifylline; Phosphodiesterase Inhibitors; Theophylline; Tumor Necrosis Factor-alpha | 1999 |
Effects of phosphodiesterase inhibitors on cytokine production by microglia.
Topics: 1-Methyl-3-isobutylxanthine; Amrinone; Animals; Anti-Ulcer Agents; Cilostazol; Colforsin; Dipyridamole; DNA Primers; Gene Expression Regulation, Enzymologic; Interleukin-1; Interleukin-6; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazines; Pyrrolidinones; Quinolines; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Rolipram; Tetrazoles; Theophylline; Tumor Necrosis Factor-alpha; Vinca Alkaloids; Xanthines | 1999 |
Chronic effects of xanthines on levels of central receptors in mice.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Brain Chemistry; Caffeine; Calcium Channels; Central Nervous System Stimulants; Cerebral Cortex; Corpus Striatum; Drug Interactions; Gene Expression Regulation; Male; Mice; Nerve Tissue Proteins; Pentoxifylline; Radioligand Assay; Receptors, Cholinergic; Receptors, Drug; Receptors, GABA; Receptors, Purinergic P1; Receptors, Serotonin; Theobromine; Theophylline; Xanthines | 1999 |
A new oral erosion controlled drug delivery system with a late burst in the release profile.
Topics: Administration, Oral; Carboxylic Acids; Colloids; Delayed-Action Preparations; Drug Delivery Systems; Excipients; Glutamic Acid; Hydrogen-Ion Concentration; Kinetics; Pentoxifylline; Polyvinyl Alcohol; Solubility; Tablets; Theophylline | 2000 |
Ibudilast attenuates astrocyte apoptosis via cyclic GMP signalling pathway in an in vitro reperfusion model.
Topics: Alkaloids; Animals; Animals, Newborn; Apoptosis; Astrocytes; Carbazoles; Cell Survival; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cytochrome c Group; Dipyridamole; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydrogen Peroxide; Indoles; Mitochondria; Pentoxifylline; Peptide Hydrolases; Phosphodiesterase Inhibitors; Purinones; Pyridines; Rats; Rats, Wistar; Reperfusion Injury; Signal Transduction; Theophylline; Vinca Alkaloids | 2001 |
Inhibition of human CYP1A2 activity in vitro by methylxanthines: potent competitive inhibition by 8-phenyltheophylline.
Topics: Acetaminophen; Aryl Hydrocarbon Hydroxylases; Binding, Competitive; Caffeine; Chlorzoxazone; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Gas Chromatography-Mass Spectrometry; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Inhibitory Concentration 50; Kinetics; Magnesium Chloride; Microsomes, Liver; Mixed Function Oxygenases; Models, Chemical; Pentoxifylline; Phenacetin; Protein Binding; Serum Albumin; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Theophylline; Time Factors; Tromethamine; Xanthines | 2001 |
Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Administration, Inhalation; Animals; Antihypertensive Agents; Cyclic AMP; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epoprostenol; Hypertension, Pulmonary; Nebulizers and Vaporizers; Pentoxifylline; Phosphodiesterase Inhibitors; Pressure; Pulmonary Gas Exchange; Rabbits; Theophylline; Vasoconstrictor Agents; Ventilation-Perfusion Ratio | 2001 |
The adenylate cyclase activator forskolin partially protects L929 cells against tumour necrosis factor-alpha-mediated cytotoxicity via a cAMP-independent mechanism.
Topics: Adenylyl Cyclases; Cell Death; Cell Line; Cell Membrane Permeability; Colforsin; Cyclic AMP; Cyclosporine; DNA Fragmentation; Humans; Pentoxifylline; Theophylline; Time Factors; Tumor Necrosis Factor-alpha | 2002 |
Methylxanthines (caffeine, pentoxifylline and theophylline) decrease the mutagenic effect of daunomycin, doxorubicin and mitoxantrone.
Topics: Antimutagenic Agents; Caffeine; Cell Survival; Daunorubicin; Doxorubicin; Mitoxantrone; Mutagenicity Tests; Pentoxifylline; Structure-Activity Relationship; Theophylline; Vibrio; Xanthenes | 2005 |
Inhibition of TNF-alpha improves indomethacin-induced enteropathy in rats by modulating iNOS expression.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Down-Regulation; Ileitis; Indomethacin; Inflammation; Jejunal Diseases; Male; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Theophylline; Tumor Necrosis Factor-alpha; Up-Regulation | 2005 |
Mutagenic activity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aminoacridines; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Caffeine; Central Nervous System Stimulants; Doxorubicin; Free Radical Scavengers; Mutagenicity Tests; Neurotoxins; Nitrogen Mustard Compounds; Pentoxifylline; Phosphodiesterase Inhibitors; Theophylline; Vibrio | 2006 |
Regulation of intestinal hPepT1 (SLC15A1) activity by phosphodiesterase inhibitors is via inhibition of NHE3 (SLC9A3).
Topics: 1-Methyl-3-isobutylxanthine; Amino Acid Transport Systems; Caco-2 Cells; Caffeine; Dipeptides; Humans; Hydrogen-Ion Concentration; Pentoxifylline; Peptide Transporter 1; Phosphodiesterase Inhibitors; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Symporters; Theophylline | 2007 |
A framework to investigate drug release variability arising from hypromellose viscosity specifications in controlled release matrix tablets.
Topics: Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Hydrochlorothiazide; Hypromellose Derivatives; Kinetics; Lactose; Methylcellulose; Models, Chemical; Molecular Weight; Pentoxifylline; Pharmaceutical Preparations; Solubility; Tablets; Technology, Pharmaceutical; Theophylline; Viscosity | 2008 |
Caffeine, pentoxifylline and theophylline form stacking complexes with IQ-type heterocyclic aromatic amines.
Topics: Amines; Caffeine; Calorimetry; Carcinogens; Heterocyclic Compounds; Mutagenicity Tests; Pentoxifylline; Salmonella typhimurium; Spectrum Analysis; Theophylline; Vibrio; Xanthines | 2011 |
cAMP-dependent cytosolic mislocalization of p27(kip)-cyclin D1 during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.
Topics: Animals; Benzenesulfonates; Bucladesine; Carcinoma, Renal Cell; Cell Line; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Cytosol; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Glutathione; Humans; Hydroquinones; Kidney Neoplasms; Male; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Niacinamide; Pentoxifylline; Phenylurea Compounds; Phosphodiesterase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; Pyridines; Rats; RNA, Small Interfering; Signal Transduction; Sorafenib; Theophylline; Tuberous Sclerosis; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2011 |
Sperm motility activation in the critically endangered booroolong frog: the effect of medium osmolality and phosphodiesterase inhibitors.
Topics: Animals; Anura; Caffeine; Fertilization in Vitro; Male; Osmolar Concentration; Pentoxifylline; Phosphodiesterase Inhibitors; Semen Analysis; Sperm Motility; Spermatozoa; Theophylline | 2017 |
Identifying drugs with disease-modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Artificial Intelligence; Case-Control Studies; Dexamethasone; Female; Humans; Insurance Claim Review; Male; Ontario; Parkinson Disease; Pentoxifylline; Pharmacoepidemiology; Theophylline | 2020 |
Unique Role of Caffeine Compared to Other Methylxanthines (Theobromine, Theophylline, Pentoxifylline, Propentofylline) in Regulation of AD Relevant Genes in Neuroblastoma SH-SY5Y Wild Type Cells.
Topics: Alzheimer Disease; Caffeine; Cell Line, Tumor; Gene Expression Regulation; Genes, Essential; Humans; Neuroblastoma; Pentoxifylline; Principal Component Analysis; Theobromine; Theophylline; Transcription, Genetic; Xanthines | 2020 |
Pentoxifylline or theophylline use in hospitalized COVID-19 patients requiring oxygen support.
Topics: Adult; COVID-19; Humans; Oxygen; Pentoxifylline; Retrospective Studies; RNA, Viral; SARS-CoV-2; Theophylline; Treatment Outcome | 2021 |
Impacts of anti-inflammatory phosphodiesterase inhibitors on a murine model of chronic pulmonary inflammation.
Topics: Aminopyridines; Animals; Anti-Inflammatory Agents; Benzamides; Cyclopropanes; Disease Models, Animal; Histone Deacetylase 2; Interleukin-8; Lung; Male; Mice, Inbred C57BL; Nicotiana; Pentoxifylline; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Smoke; Smoking; Theophylline; Tumor Necrosis Factor-alpha | 2021 |
Methylxanthines Induce a Change in the AD/Neurodegeneration-Linked Lipid Profile in Neuroblastoma Cells.
Topics: Alzheimer Disease; Caffeine; Cell Line, Tumor; Cholesterol; Humans; Lipids; Neural Stem Cells; Neuroblastoma; Neurodegenerative Diseases; Pentoxifylline; Theobromine; Theophylline; Triglycerides; Xanthines | 2022 |